Previous 10 | Next 10 |
home / stock / coprf / coprf news
TORONTO, April 30, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare investment management company that seeks out disruptive technologies, ground-breaking innovations and exclusive partnerships to help combat COVID-19, today ...
TORONTO, April 15, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce it is hosting a Corporate Update webinar, on Thursday, April 15 th at 1 pm ET that will provide investors with an update on t...
TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) , a healthcare company that focuses on commercializing technologies to help combat COVID-19, announced today that its wholly-owned subsidiary, Collection Sites, LLC ...
Medivolve's (COPRF) wholly owned subsidiary, Collection Sites realized the sale of 20,574 tests with 59% of sales being insurance pay and balance in cash.The company continued to see the strongest demand for antigen tests, followed by antibody and then PCR tests."March was another solid ...
TORONTO, April 06, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to provide a sales update for its wholly owned subsidiary, Collection Sites, LLC. During the month of March, Collection Sites realized the sale of 20,574...
Collection Sites, LLC Named AditxtScore™ Channel Partner to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring through its Mobile Testing Centers PR Newswire MOUNTAIN VIEW, Calif. , April 1, 2021 /PRNewswire/ -- Aditx Therapeutics, Inc....
TORONTO, April 01, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) today announced that its wholly owned subsidiary, Collection Sites, LLC will offer AditxtScore™ for COVID-19 through its mobile testing centres. Aditx Therapeutic...
TORONTO, March 30, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce that its wholly-owned subsidiary Collection Sites, LLC has signed an agreement with Transplant Genomics to offer free COVID-19 PCR tests at its mo...
An Emerging Markets Sponsored Commentary ORLANDO, Fla., March 23, 2021 (GLOBE NEWSWIRE) -- Medical Technology Disruptor. Normally, we write our own headlines for the pages of the Emerging Market Report but in this instance there is no finer title than the one t...
TORONTO, March 18, 2021 (GLOBE NEWSWIRE) -- We were informed by the client Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC), in the fifth paragraph, the month January should be February. The corrected sentence should read: "During the month of February, th...
News, Short Squeeze, Breakout and More Instantly...
TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“ Medivolve ” or the “ Company “) (NEO: MEDV) (OTC: COPRF) (FRA: 4NC), a healthcare technology and services company, has began its transition towards other service offerings outside of COV...
TORONTO, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“ Medivolve ” or the “ Company ”) (NEO: MEDV; OTC: COPRF; FRA: 4NC) is pleased to announce the launch of an investor marketing campaign to raise awareness of the Company in the investing community...
TORONTO, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“ Medivolve ” or the “ Company ”) (NEO: MEDV; OTC: COPRF; FRA: 4NC), a healthcare technology company that seeks to improve the US healthcare system by leveraging a bespoke telehealth platform, cli...